Reference
[1] S. Tsai, X. Clemente-Casares, P. Santamaria, CD8(+) Tregs in
autoimmunity: learning ”self”-control from experience, Cell Mol Life Sci
68(23) (2011) 3781-95.
[2] S. Mishra, S. Srinivasan, C. Ma, N. Zhang, CD8(+) Regulatory T
Cell - A Mystery to Be Revealed, Front Immunol 12 (2021) 708874.
[3] A.R. Schenkel, L.C. Kingry, R.A. Slayden, The ly49 gene family.
A brief guide to the nomenclature, genetics, and role in intracellular
infection, Front Immunol 4 (2013) 90.
[4] C. Viant, A. Fenis, G. Chicanne, B. Payrastre, S. Ugolini, E.
Vivier, SHP-1-mediated inhibitory signals promote responsiveness and
anti-tumour functions of natural killer cells, Nat Commun 5 (2014) 5108.
[5] H. Zhu, M. Zhao, C. Chang, V. Chan, Q. Lu, H. Wu, The complex
role of AIM2 in autoimmune diseases and cancers, Immun Inflamm Dis 9(3)
(2021) 649-665.
[6] M. Yang, D. Long, L. Hu, Z. Zhao, Q. Li, Y. Guo, Z. He, M. Zhao,
L. Lu, F. Li, H. Long, H. Wu, Q. Lu, AIM2 deficiency in B cells
ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6
axis-mediated B-cell differentiation, Signal Transduct Target Ther 6(1)
(2021) 341.
[7] D. Verma, S.Z. Fekri, G. Sigurdardottir, C. Bivik Eding, C.
Sandin, C. Enerbäck, Enhanced Inflammasome Activity in Patients with
Psoriasis Promotes Systemic Inflammation, J Invest Dermatol 141(3)
(2021) 586-595.e5.
[8] Y. Chen, Q. Fujuan, E. Chen, B. Yu, F. Zuo, Y. Yuan, X. Zhao, C.
Xiao, Expression of AIM2 in Rheumatoid Arthritis and Its Role on
Fibroblast-Like Synoviocytes, Mediators Inflamm 2020 (2020) 1693730.
[9] A.G. Vakrakou, I.P. Svolaki, K. Evangelou, V.G. Gorgoulis, M.N.
Manoussakis, Cell-autonomous epithelial activation of AIM2 (absent in
melanoma-2) inflammasome by cytoplasmic DNA accumulations in primary
Sjögren’s syndrome, J Autoimmun 108 (2020) 102381.
[10] G. Guggino, D. Mauro, A. Rizzo, R. Alessandro, S. Raimondo,
A.S. Bergot, M.A. Rahman, J.J. Ellis, S. Milling, R. Lories, D. Elewaut,
M.A. Brown, R. Thomas, F. Ciccia, Inflammasome Activation in Ankylosing
Spondylitis Is Associated With Gut Dysbiosis, Arthritis Rheumatol 73(7)
(2021) 1189-1199.
[11] M. Zhang, C. Jin, Y. Yang, K. Wang, Y. Zhou, Y. Zhou, R. Wang,
T. Li, R. Hu, AIM2 promotes non-small-cell lung cancer cell growth
through inflammasome-dependent pathway, J Cell Physiol 234(11) (2019)
20161-20173.
[12] J.E. Wilson, A.S. Petrucelli, L. Chen, A.A. Koblansky, A.D.
Truax, Y. Oyama, A.B. Rogers, W.J. Brickey, Y. Wang, M. Schneider, M.
Mühlbauer, W.C. Chou, B.R. Barker, C. Jobin, N.L. Allbritton, D.A.
Ramsden, B.K. Davis, J.P. Ting, Inflammasome-independent role of AIM2 in
suppressing colon tumorigenesis via DNA-PK and Akt, Nat Med 21(8) (2015)
906-13.
[13] R.E. Dawson, V. Deswaerte, A.C. West, K. Tang, A.J. West, J.J.
Balic, L.J. Gearing, M.I. Saad, L. Yu, Y. Wu, P.S. Bhathal, B. Kumar,
J.T. Chakrabarti, Y. Zavros, H. Oshima, D.M. Klinman, M. Oshima, P. Tan,
B.J. Jenkins, STAT3-mediated upregulation of the AIM2 DNA sensor links
innate immunity with cell migration to promote epithelial
tumourigenesis, Gut (2021).
[14] W.C. Chou, Z. Guo, H. Guo, L. Chen, G. Zhang, K. Liang, L. Xie,
X. Tan, S.A. Gibson, E. Rampanelli, Y. Wang, S.A. Montgomery, W.J.
Brickey, M. Deng, L. Freeman, S. Zhang, M.A. Su, X. Chen, Y.Y. Wan, J.P.
Ting, AIM2 in regulatory T cells restrains autoimmune diseases, Nature
591(7849) (2021) 300-305.
[15] R. Gandhi, D. Kumar, E.J. Burns, M. Nadeau, B. Dake, A. Laroni,
D. Kozoriz, H.L. Weiner, F.J. Quintana, Activation of the aryl
hydrocarbon receptor induces human type 1 regulatory T cell-like and
Foxp3(+) regulatory T cells, Nat Immunol 11(9) (2010) 846-53.
[16] H.J. Kim, R.A. Barnitz, T. Kreslavsky, F.D. Brown, H. Moffett,
M.E. Lemieux, Y. Kaygusuz, T. Meissner, T.A. Holderried, S. Chan, P.
Kastner, W.N. Haining, H. Cantor, Stable inhibitory activity of
regulatory T cells requires the transcription factor Helios, Science
350(6258) (2015) 334-9.
[17] S. Mishra, W. Liao, Y. Liu, M. Yang, C. Ma, H. Wu, M. Zhao, X.
Zhang, Y. Qiu, Q. Lu, N. Zhang, TGF-β and Eomes control the homeostasis
of CD8+ regulatory T cells, J Exp Med 218(1) (2021).